Outcome of Ceftazidime/Avibactam Versus Alternative Antibiotics for Treatment of Carbapenem-Resistant <i>Enterobacterales</i> Bacteremia in Patients With Hematologic Malignancies. [PDF]
Jang HM +9 more
europepmc +1 more source
Efficacy and safety of ceftazidime-avibactam versus tigecycline in the treatment of pneumonia caused by carbapenem-resistant <i>Klebsiella pneumoniae</i>. [PDF]
Yang T, Xu M, Cao L, Shi Y, Shi X.
europepmc +1 more source
Ceftazidime-Avibactam-Induced Neurotoxicity Manifesting as Seizure in an Older Adult: A Case Report. [PDF]
Li Z, Li C, Zhao P, Han Y, Lu N.
europepmc +1 more source
Assessing the Synergistic Potential of Ceftazidime-avibactam and Aztreonam against Metallo-beta-lactamase Producing Enterobacterales by Disc Elution and Disc E Strip - Synergy Method. [PDF]
Linsy KMA +4 more
europepmc +1 more source
Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis. [PDF]
Gatti M, De Paola R, Giorgi B, Pea F.
europepmc +1 more source
Disease severity modifies the ceftazidime-avibactam exposure-response relationship in critically ill patients: a retrospective study. [PDF]
Qian S, Xu D, Xu Y, Qi H, Liang P.
europepmc +1 more source
Cost-effectiveness of empirical ceftazidime-avibactam for hospital-acquired urinary tract infections: a modeling study identifying key beneficiary subgroups. [PDF]
Wu BS +8 more
europepmc +1 more source
Emergence of ceftazidime-avibactam resistance mediated by KPC variants KPC-71 and KPC-78 in ST463 <i>Pseudomonas aeruginosa</i>. [PDF]
Yang F +12 more
europepmc +1 more source
Performance evaluation of antimicrobial susceptibility testing methods for ceftazidime-avibactam and imipenem-relebactam against Klebsiella pneumoniae and Pseudomonas aeruginosa. [PDF]
Xu X, Lu E, Wu L.
europepmc +1 more source

